Natpara Approval Status
- FDA approved: No
- Brand name: Natpara
- Generic name: recombinant human parathyroid hormone
- Company: NPS Pharmaceuticals, Inc.
- Treatment for: Hypoparathyroidism
Natpara (recombinant human parathyroid hormone) is a bioengineered replica of human parathyroid hormone 1-84 in development for the treatment of hypoparathyroidism.
FDA Approval Status for Natpara
|Sep 5, 2012||NPS Pharmaceuticals Expects to File Natpara BLA in Mid-2013|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.